Advanced search
Publication Cover
Leukemia & Lymphoma Volume 61, 2020 - Issue 14
Submit an article Journal homepage
1,211
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Busulfan, melphalan, and bortezomib compared to melphalan as a high dose regimen for autologous hematopoietic stem cell transplantation in multiple myeloma: long term follow up of a novel high dose regimen

Patrick Hagena Stritch School of Medicine, Loyola University Chicago, Maywood, IL, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-3428-1667View further author information
ORCID Icon,
Anita D'Souzab Division of Hematology Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USAView further author information
,
Parameswaran Harib Division of Hematology Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USAView further author information
,
Omar Davilac CIBMTR, Medical College of Wisconsin, Milwaukee, WI, USAView further author information
,
Mei-Jie Zhangb Division of Hematology Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USAView further author information
,
David H. Vesoled John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USAView further author information
,
Scott E. Smitha Stritch School of Medicine, Loyola University Chicago, Maywood, IL, USAView further author information
,
Tulio E. Rodrigueze Department of Hematology Oncology, Advocate Lutheran General Hospital, Chicago, IL, USAView further author information
&
Patrick J. Stiffa Stritch School of Medicine, Loyola University Chicago, Maywood, IL, USAView further author information
 show all
Pages 3484-3492 | Received 03 Jun 2020, Accepted 11 Aug 2020, Published online: 31 Aug 2020

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.